These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 8810786)

  • 21. [Treatment of arrhythmias in chronic cardiac insufficiency].
    Motté G; Slama M; Drieu L
    Arch Mal Coeur Vaiss; 1990 Nov; 83(13):1963-6. PubMed ID: 1980188
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiarrhythmic properties of beta-blockers.
    Haverkamp W; Hindricks G; Gülker H
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S29-32. PubMed ID: 11527133
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Combination of celiprolol and amiodarone in the treatment of recurrent ventricular tachycardia].
    Tonet J; Hidden F; Naditch L; Coutte R; Himbert C; Frank R
    Ann Cardiol Angeiol (Paris); 1996 Jan; 45(1):18-23. PubMed ID: 8815771
    [TBL] [Abstract][Full Text] [Related]  

  • 24. LB-46, a new beta-adrenergic receptor blocking agent in cardiac arrhythmias.
    Storstein L
    Acta Med Scand; 1972 May; 191(5):423-8. PubMed ID: 4402323
    [No Abstract]   [Full Text] [Related]  

  • 25. Pharmacology of antiarrhythmic drugs in elderly patients.
    Frishman WH; Aronow WS
    Clin Geriatr Med; 2012 Nov; 28(4):575-615. PubMed ID: 23101572
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antiarrhythmic treatment of atrial arrhythmias.
    Kulbertus HE
    J Cardiovasc Pharmacol; 1991; 17 Suppl 6():S32-5. PubMed ID: 1723115
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Anti-arrhythmic effect of oral propafenone. Apropos of 70 cases].
    Coumel P; Leclercq JF; Assayag P; Maisonblanche P; Cauchemez B
    Arch Mal Coeur Vaiss; 1984 Nov; 77(12):1370-82. PubMed ID: 6439161
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparison of seven antiarrhythmic drugs in patients with ventricular tachyarrhythmias. Electrophysiologic Study versus Electrocardiographic Monitoring Investigators.
    Mason JW
    N Engl J Med; 1993 Aug; 329(7):452-8. PubMed ID: 8332150
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics of landiolol hydrochloride, a new ultra-short-acting beta-blocker, in patients with cardiac arrhythmias.
    Atarashi H; Kuruma A; Yashima M; Saitoh H; Ino T; Endoh Y; Hayakawa H
    Clin Pharmacol Ther; 2000 Aug; 68(2):143-50. PubMed ID: 10976545
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Spectrum of effects of beta receptor blockade in cardiac arrhythmias].
    Lüderitz B
    Z Kardiol; 1986; 75 Suppl 5():41-6. PubMed ID: 2435070
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [What is the latest in anti-arrhythmia therapy?].
    Gloor HO
    Schweiz Med Wochenschr; 1991 Nov; 121(47):1711-4. PubMed ID: 1720259
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Ischemic disorders of cardiac rhythm: effects of the autonomic nervous system on electrophysiologic findings and pharmacotherapy].
    Gülker H; Thale J
    Z Kardiol; 1986; 75 Suppl 5():15-34. PubMed ID: 3825228
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment and prevention of sudden cardiac death--what have we learnt from randomised clinical trials?
    Kam RM; Teo WS; Koh TH; Lim YL
    Singapore Med J; 1999 Nov; 40(11):707-10. PubMed ID: 10709412
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Beta-Adrenergic blockers as antiarrhythmic and antifibrillatory compounds: an overview.
    Singh BN
    J Cardiovasc Pharmacol Ther; 2005 Jun; 10 Suppl 1():S3-S14. PubMed ID: 15965570
    [TBL] [Abstract][Full Text] [Related]  

  • 35. General principles of antiarrhythmic therapy for ventricular tachyarrhythmias.
    Landers MD; Reiter MJ
    Am J Cardiol; 1997 Oct; 80(8A):31G-44G. PubMed ID: 9354410
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ventricular antiarrhythmic effects of beta-adrenergic blocking drugs: a review of mechanism and clinical studies.
    Pratt C; Lichstein E
    J Clin Pharmacol; 1982; 22(8-9):335-47. PubMed ID: 6127349
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiarrhythmic properties of ranolazine--from bench to bedside.
    Tzeis S; Andrikopoulos G
    Expert Opin Investig Drugs; 2012 Nov; 21(11):1733-41. PubMed ID: 22916846
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiarrhythmic mechanisms of beta blocker therapy.
    Grandi E; Ripplinger CM
    Pharmacol Res; 2019 Aug; 146():104274. PubMed ID: 31100336
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of ivabradine and beta-blocker therapy on dobutamine-induced ventricular arrhythmias.
    Mert KU; Mert GÖ; Morrad B; Tahmazov S; Mutlu F; Çavuşoglu Y
    Kardiol Pol; 2017; 75(8):786-793. PubMed ID: 28541596
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical pharmacology of antiarrhythmic drugs.
    Capucci A; Aschieri D; Villani GQ
    Drugs Aging; 1998 Jul; 13(1):51-70. PubMed ID: 9679209
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.